pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Vyvgart · news · pharmadog
← back to Vyvgart
News mentioning Vyvgart
10
stories
3d
Argenx jumps on Phase 3 data for blockbuster Vyvgart
biopharma dive
3d
Argenx declares Phase 3 win for Vyvgart Hytrulo in autoimmune myositis
endpoints
24d
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
biopharma dive
24d
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
biospace
24d
STAT+: Argenx to buy Forte Biosciences for $2.2B
stat
25d
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
fiercebiotech
Jun 10, 26
Sanofi stops immune drug trial in latest research setback
biopharma dive
Jun 1, 26
2026 Orphan Drugs Report: A safe(r) passage amid stormy waters?
biopharma dive
May 11, 26
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
biopharma dive
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
